Pfizer's Stock Is a Buy. Here Are Six Reasons Why.

With Pfizer dropping 2024 first-quarter earnings yesterday, the stock stands out as a top buy for several compelling reasons. Here are six of the most important. Six reasons to buy

41%
OFF

Here's Why Pfizer (PFE) Is A Strong Value Stock | Nasdaq

2 weeks from now

Oct 30, 2024 · Here's Why Pfizer (PFE) is a Strong Value Stock October 30, 2024 — 09:40 am EDT. ... (Strong Buy) stocks have produced an unmatched +25.41% average annual return …

nasdaq.com

7%
OFF

Pfizer Just Reassured Investors, But Is The Stock A Buy?

2 weeks from now

Dec 22, 2024 · At the same time, if you're interested in collecting a dividend with a toothsome forward yield of 6.7%, right now looks like a great time to buy more shares or invest for the first …

fool.com

$1.06
OFF

Pfizer Stock Rises On Covid Spike; But Is PFE Stock A Buy?

2 weeks from now

Jan 7, 2025 · So, is Pfizer stock a buy or a sell today? Pfizer Stock Fundamentals In the September quarter, Pfizer earned an adjusted $1.06 per share on $17.7 billion in sales.

investors.com

6%
OFF

Is Pfizer Stock A Buy Near 10-Year Lows For Its 6% Dividend Yield?

2 weeks from now

Pfizer stock is fresh off the lowest price levels shareholders have seen in a decade. Why is PFE stock so low, and should you follow the CEO's lead and buy this high-yield pharma stock?

barchart.com

6%
OFF

5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be …

2 weeks from now

Mar 18, 2024 · Here are five reasons why buying this 6%-yielding dividend stock could be a brilliant move. 1. COVID-19 trough. Most of Pfizer's recent woes can be blamed on declining …

yahoo.com

$36.00
OFF

Pfizer’s Growth Potential And Strategic Focus Justify Buy Rating …

2 weeks from now

2 days ago · Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer (PFE – Research Report) and keeping the price target at $36.00. Discover outperforming stocks and …

businessinsider.com

52%
OFF

Is Pfizer A Buy Right Now Or A Value Trap? | The Motley Fool

2 weeks from now

Oct 3, 2024 · Pfizer (PFE-0.52%) has been around for 175 years, selling a wide range of drugs in various treatment areas over time. But this pharma giant truly became a household name a …

fool.com

6%
OFF

Pfizer (NYSE:PFE) Stock Price Down 0.6% - What's Next?

2 weeks from now

15 hours ago · During the same period in the previous year, the business earned ($0.17) earnings per share. The company's quarterly revenue was up 31.2% on a year-over-year basis. …

marketbeat.com

891%
OFF

Is Pfizer Stock A Bargain For Long-Term Investors?

2 weeks from now

Nov 4, 2024 · 3 Reasons to Buy Pfizer Stock Like There's No Tomorrow. 891%. Premium Investing Services. Invest better with The Motley Fool. Get stock recommendations, portfolio …

fool.com

FAQs about Pfizer's Stock Is a Buy. Here Are Six Reasons Why. Coupon?

Is Pfizer's stock a buy?

Pfizer's Stock Is a Buy. Here Are Six Reasons Why. Pfizer may be one of the biggest bargains in the market today. The drugmaker offers an attractive yield, a rock-bottom valuation, and an underappreciated cancer pipeline. Long-term investors shouldn't hesitate to add this top dividend stock to their portfolios right now. ...

How has Pfizer's stock performed over the past 3 years?

All of this has weighed on Pfizer's stock performance, leaving the shares down more than 30% over the past three years. Valuation has halved from a year ago, with Pfizer shares today trade for only 10 times forward earnings estimates. ...

Should you invest in Pfizer stock?

However, despite its recent struggles, there remain excellent reasons to invest in Pfizer stock. In fact, let's consider seven of them right now. It's not that rare for drugmakers to go through periods of declining sales. Usually, it is because of patent cliffs. ...

Is Pfizer's stock undervalued?

The company’s robust acquisitions strategy, funded by COVID-related cash influxes, has strengthened its pipeline and positioned it well against its biopharma peers. Overall, Seigerman believes that Pfizer’s shares are undervalued given its strong fundamentals, potential for top-line growth, and margin expansion, justifying the Buy rating. ...

Is Pfizer a top Buy Right Now?

As rate cuts continue to drive a rotation into high-yielding dividend stocks with compelling valuations, this high-yielding pharmaceutical leader scans as a top buy right now. That said, Pfizer's transformation is far from over, with several important challenges, such as its upcoming patent cliff, remaining firmly in view. ...

Does Pfizer's stock trade at 11 times forward earnings?

Speaking to this point, Pfizer's stock trades at around 11 times forward earnings. On the other hand, its big-pharma peer group averages 17 on this key valuation metric. ...